Your browser doesn't support javascript.
loading
Isoindolinone ureas: a novel class of KDR kinase inhibitors.
Curtin, Michael L; Frey, Robin R; Heyman, H Robin; Sarris, Kathy A; Steinman, Douglas H; Holmes, James H; Bousquet, Peter F; Cunha, George A; Moskey, Maria D; Ahmed, Asma A; Pease, Lori J; Glaser, Keith B; Stewart, Kent D; Davidsen, Steven K; Michaelides, Michael R.
Afiliação
  • Curtin ML; Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6100, USA. mike.curtin@abbott.com
Bioorg Med Chem Lett ; 14(17): 4505-9, 2004 Sep 06.
Article em En | MEDLINE | ID: mdl-15357981
ABSTRACT
A series of substituted isoindolinone ureas was prepared and evaluated for enzymatic and cellular inhibition of KDR kinase activity. Several of these analogs, such as 14c, are potent inhibitors of KDR both enzymatically (< 50 nM) and cellularly < or = 100 nM). A 3D KDR/CDK2/MAP kinase overlay model with several structurally related tyrosine kinase inhibitors was used to predict the binding interactions of the isoindolinone ureas with the KDR active site.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ureia / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores Enzimáticos / Indóis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2004 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ureia / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores Enzimáticos / Indóis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2004 Tipo de documento: Article